Infective Endocarditis Due to Penicillin-Resistant Viridans Group Streptococci
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The emergence of viridans group streptococci that are relatively or fully resistant to penicillin is increasingly being recognized worldwide, but only a scant number of penicillin-resistant isolates have been described as a cause of infective endocarditis. Because of the paucity of data, it has been difficult to define optimal treatment regimens for this syndrome. Thus, recommendations for therapy have largely been made on the basis of consensus opinion. METHODS: We retrospectively identified a cohort of patients with infective endocarditis due to penicillin-resistant viridans group streptococci who were seen at the Mayo Clinic (Rochester, MN) between January 1967 and April 2006. Demographic characteristics, clinical features, treatment regimens, and outcomes were analyzed. Mean values are shown with standard deviations. RESULTS: Twenty-nine patients were identified over the 38.5-year study period. Nineteen patients with native valve endocarditis were cured; 9 of these 19 patients received a 2.3+/-0.4-week antibiotic regimen consisting of penicillin and an aminoglycoside, and 8 of these 19 patients received treatment courses of 5.1+/-1.4 weeks' duration that consisted of either a bimodal combination regimen with a penicillin or ceftriaxone and an aminoglycoside or ceftriaxone monotherapy. Nine of 10 patients with prosthetic valve infection were cured with 4.1+/-0.6-week regimens that consisted of either a combination regimen or monotherapy with vancomycin or ceftriaxone. Mean duration of follow-up after hospital discharge was 9.1 years. CONCLUSIONS: Outcomes of this relatively large population of patients with endocarditis with a prolonged duration of follow-up indicate that the application of current treatment guidelines should be successful in most patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
Ferraro, M. J. (2000) · Cited by 16,875
Proposed Modifications to the Duke Criteria for the Diagnosis of Infective Endocarditis
Li, J. S., Sexton, D. J., Mick, N., Nettles, R., Fowler, V. G., Ryan, T., Bashore, T., & Corey, G. R. (2000) · Clinical Infectious Diseases · doi:10.1086/313753 · Cited by 4,027
Durack, D. T., Lukes, A. S., Bright, D. K., & Service, D. E. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90143-0 · Cited by 2,572
Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Bolger, A. F., Levison, M. E., Ferrieri, P., Gerber, M. A., Tani, L. Y., Gewitz, M. H., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.165564 · Cited by 1,707
Self-citationInfective Endocarditis in Adults
Mylonakis, E., & Calderwood, S. B. (2001) · New England Journal of Medicine · doi:10.1056/nejmra010082 · Cited by 1,324
Temporal Trends in Infective Endocarditis: A Population-Based Study in Olmsted County, Minnesota
Tleyjeh, I. M., Steckelberg, J. M., Murad, H. S., Anavekar, N. S., Ghomrawi, H. M. K., Mirzoyev, Z., Moustafa, S. E., Hoskin, T. L., Mandrekar, J. N., Wilson, W. R., et al. (2005) · JAMA · doi:10.1001/jama.293.24.3022 · Cited by 366
Self-citationDoern, G. V., Ferraro, M. J., Brueggemann, A. B., & Ruoff, K. L. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.4.891 · Cited by 297
Journal of microbiology, immunology and infection : Wei mian yu gan ran za zhi.
hui, Z. M. W. S. W. X., hui, Z. M. M. Y. X., hui, Z. M. G. R. Z. Y. X., hui, T. G. R. Z. Y. X., & ScienceDirect (1998) · Cited by 159
Marron, A., Carratala, J., Gonzalez-Barca, E., Fernandez-Sevilla, A., Alcaide, F., & Gudiol, F. (2000) · Clinical Infectious Diseases · doi:10.1086/317460 · Cited by 149
Teng, L. (1998) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/41.6.621 · Cited by 129
Cited by
Habib, G., Lancellotti, P., Antunes, M. J., Bongiorni, M. G., Casalta, J.-P., Del Zotti, F., Dulgheru, R., El Khoury, G., Erba, P. A., Iung, B., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv319 · Cited by 4,997
“Treatment outcomes were similar in PVE and NVE.(145) Hence antibiotic therapy for penicillin-resistant and penicillin-susceptible oral streptococci is qualitatively similar (Table 16).”
Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Tleyjeh, I. M., Rybak, M. J., Barsic, B., Lockhart, P. B., Gewitz, M. H., Levison, M. E., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000296 · Cited by 3,232
Self-citationGuidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009)
Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and by the International Society of Chemotherapy (ISC) for Infection and Cancer, Habib, G., Hoen, B., Tornos, P., Thuny, F., Prendergast, B., Vilacosta, I., Moreillon, P., de Jesus Antunes, M., Thilen, U., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp285 · Cited by 2,014
2023 ESC Guidelines for the management of endocarditis
Delgado, V., Ajmone Marsan, N., de Waha, S., Bonaros, N., Brida, M., Burri, H., Caselli, S., Doenst, T., Ederhy, S., Erba, P. A., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad193 · Cited by 1,754
Self-citationGould, F. K., Denning, D. W., Elliott, T. S. J., Foweraker, J., Perry, J. D., Prendergast, B. D., Sandoe, J. A. T., Spry, M. J., & Watkin, R. W. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr450 · Cited by 593
Que, Y.-A., & Moreillon, P. (2011) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2011.43 · Cited by 243
JCS 2017 Guideline on Prevention and Treatment of Infective Endocarditis
Nakatani, S., Ohara, T., Ashihara, K., Izumi, C., Iwanaga, S., Eishi, K., Okita, Y., Daimon, M., Kimura, T., Toyoda, K., et al. (2019) · Circulation Journal · doi:10.1253/circj.cj-19-0549 · Cited by 179
2015 ESC Guidelines for the management of infective endocarditis
Habib, G., Lancellotti, P., Antunes, M. J., Bongiorni, M. G., Casalta, J.-P., Del Zotti, F., Dulgheru, R., El Khoury, G., Erba, P. A., Iung, B., et al. (2015) · Kardiologia Polska · doi:10.5603/kp.2015.0227 · Cited by 165
DeSimone, D. C., Tleyjeh, I. M., Correa de Sa, D. D., Anavekar, N. S., Lahr, B. D., Sohail, M. R., Steckelberg, J. M., Wilson, W. R., & Baddour, L. M. (2012) · Circulation · doi:10.1161/circulationaha.112.095281 · Cited by 164
Self-citationAbundance and diversity of resistomes differ between healthy human oral cavities and gut
Carr, V. R., Witherden, E. A., Lee, S., Shoaie, S., Mullany, P. P., Proctor, G., Gómez-Cabrero, D., & Moyes, D. L. (2020) · Nature Communications · doi:10.1038/s41467-020-14422-w · Cited by 129
Collagen‐binding proteins of Streptococcus mutans and related streptococci
Avilés-Reyes, A., Miller, J. E., Lemos, J. A. C., & Abranches, J. (2016) · Molecular Oral Microbiology · doi:10.1111/omi.12158 · Cited by 95
“mutans can evade antibiotic treatment (Knoll et al., 2007; Jung et al., 2012; Foster et al., 2014).”
Current Challenges in the Management of Infective Endocarditis
Cuervo, G., Escrihuela-Vidal, F., Gudiol, C., & Carratalà, J. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.641243 · Cited by 88
“This antibiotic combination is also recommended for treating infections caused by the viridans group streptococci that are partially or fully resistant to penicillin, although this recommendation is based on less robust evidence (128, 129).”
BackgroundGarcía-de-la-Mària, C., Pericàs, J. M., del Río, A., Castañeda, X., Vila‐Farrés, X., Armero, Y., Espinal, P., Cervera, C., Soy, D., Falces, C., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01921-12 · Cited by 63
Yavuz, S. Ş., Şensoy, A., Kaşıkçıoğlu, H., Çeken, S., Deniz, D., Yavuz, A., Koçak, F., Midilli, K., Eren, M., & Yekeler, İ. (2014) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2014.11.007 · Cited by 59
Infectious endocarditis and infection of intracardiac devices in adults. Clinical guidelines 2021
Демин, А. А., Kobalava, Z. D., Skopin, I. I., Tyurin, P. V., Boytsov, S. A., Golukhova, E. Z., Гордеев, М. Л., Gudymovich, V. D., Demchenko, E. A., Дробышева, В. П., et al. (2022) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2022-5233 · Cited by 69
Ding, D., Zhu, J., Gao, Y., Yang, F., Ma, Y., Cheng, X., Li, J., Dong, P., Yang, H., & Chen, S. (2021) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2021.150685 · Cited by 49
Clinical utility of daptomycin in infective endocarditis caused by Gram-positive cocci
Cervera, C., Castañeda, X., Pericàs, J. M., del Río, A., de la Mària, C. G., Mestres, C. A., Falces, C., Marco, F., Moreno, A., & Miró, J. M. (2011) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2010.11.038 · Cited by 36
New Perspectives of Infections in Cardiovascular Disease
Fong, I. W. (2009) · Current Cardiology Reviews · doi:10.2174/157340309788166679 · Cited by 36
“0 ug/ml), were identified over the past 38 years (^ 8 cases per decade) [86].”
BackgroundCunha, B. A., D’Elia, A., Pawar, N., & Schoch, P. E. (2009) · Heart & Lung · doi:10.1016/j.hrtlng.2009.01.004 · Cited by 32
La endocarditis infecciosa en el siglo xxi: cambios epidemiológicos, terapéuticos y pronósticos
Fernández‐Hidalgo, N., & Almirante, B. (2012) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2011.11.005 · Cited by 50
Matsui, N., Ito, M., Kuramae, H., Inukai, T., Sakai, A., & Okugawa, M. (2012) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-012-0465-9 · Cited by 28
“mitis has become prevalent among clinically isolated strains from bacteremic patients, especially in neutropenia or other immunocompromised conditions [2–11].”
BackgroundHabib, G., Hoen, B., Tornos, P., Thuny, F., Prendergast, B., Vilacosta, I., Moreillon, P., Antunes, M. J., Thilén, U. J., Lekakis, J. P., et al. (2009) · Revista Española de Cardiología · doi:10.1016/s0300-8932(09)73131-8 · Cited by 43
Fujitani, S., Rowlinson, M., & George, W. L. (2008) · Clinical Infectious Diseases · doi:10.1086/529199 · Cited by 24
“We believe that these data [7] support the recommendation that IE due to VGS that is relatively resistant or resistant to penicillin G should be treated with either penicillin G or ceftriaxone and gentamicin.”
BackgroundYim, J., Smith, J. R., Singh, N. B., Rice, S., Stamper, K. C., de la Mària, C. G., Bayer, A. S., Mishra, N. N., Miró, J. M., Tran, T. T., et al. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx130 · Cited by 25
Aprile, I. G., Bordieri, C., Gilardi, A., Milazzo, M. L., Russo, G., Santis, F. D., Frusciante, R., Iannaccone, E., Erra, C., Ricci, E., et al. (2013) · PubMed · Cited by 31
Be careful about MICs to amoxicillin for patients with Streptococci-related infective endocarditis
Pilmis, B., Lourtet-Hascoët, J., Barraud, O., Piau, C., Isnard, C., Héry-Arnaud, G., Amara, M., Mérens, A., Farfour, É., Thomas, E., et al. (2019) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2019.03.002 · Cited by 29
Pericàs, J. M., Nathavitharana, R. R., García-de-la-Mària, C., Falces, C., Ambrosioni, J., Almela, M., García‐González, J., Quintana, E., Marco, F., Moreno, A., et al. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00516-19 · Cited by 24
Treatment strategies for infective endocarditis
Chopra, T., & Kaatz, G. W. (2010) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560903496430 · Cited by 22
Knoll, B. M., Baddour, L. M., & Wilson, W. R. (2010) · Elsevier eBooks · doi:10.1016/b978-0-443-06839-3.00078-3 · Cited by 22
Self-citationGuía ESC 2015 sobre el tratamiento de la endocarditis infecciosa
Habib, G., Lancellotti, P., Antunes, M. J., Bongiorni, M. G., Casalta, J., Zotti, F. D., Dulgheru, R., Khoury, G. A. E., Erba, P. A., Iung, B., et al. (2015) · Revista Española de Cardiología · doi:10.1016/j.recesp.2015.11.015 · Cited by 54
Diagnosis, treatment and prevention of infective endocarditis: Turkish consensus report-2019*
Yavuz, S. Ş., Akar, A. R., Aydoğdu, S., Deniz, D. B., Demir, H., Hazırolan, T., Ozatik, M. A., Özer, N., Sargın, M., Topçuoğlu, N., et al. (2020) · Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology · doi:10.5543/tkda.2020.89689 · Cited by 25
Contemporary Drug Treatment of Infective Endocarditis
Sabe, M., Shrestha, N. K. M., & Menon, V. (2013) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-013-0015-6 · Cited by 15
Clinical Guideline for the Diagnosis and Treatment of Cardiovascular Infections
The Korean Society of Infectious Diseases, Korean Society for Chemotherapy, The Korean Society of Cardiology, & The Korean Society for Thoracic and Cardiovascular Surgery (2011) · Infection and Chemotherapy · doi:10.3947/ic.2011.43.2.129 · Cited by 13
Health Science Education: Reviewing a Framework for Problem‐Based Learning
McCarlie, V. W., & Orr, D. L. (2010) · Journal of Dental Education · doi:10.1002/j.0022-0337.2010.74.5.tb04894.x · Cited by 12
“More recently, it has been shown that penicillinresistant viridans streptococci are actually causing IE by colonizing more virulent bacteria.(18,19) Since “viridans group streptococci are the causative microorganisms in 40%–60% of cases of community-acquired, native-valve endocarditis,” this has the potential of becom…”
BackgroundZapata, B., Alvarez, D. N., Farah, S., García-de-la-Maria, C., Miró, J. M., Sakoulas, G., Bayer, A. S., & Mishra, N. N. (2018) · Current Microbiology · doi:10.1007/s00284-018-1491-3 · Cited by 12
“mitis-oralis strains are a particularly problematic issue in IE, as they are frequently resistant in vitro to the penicillins and many cephalosporin antibiotics [4, 13, 14, 28, 29].”
BackgroundEscrihuela-Vidal, F., Berbel, D., Fernández‐Hidalgo, N., Escolà‐Vergé, L., Muñoz, P., Olmedo, M., Goenaga, M. Á., Goikoetxea, J., Fariñas, M. C., de Alarcón, A., et al. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciad375 · Cited by 11
Infective endocarditis: a retrospective cohort study
O'Connor, C. T., O’Rourke, S., Buckley, A., Murphy, R. T., Crean, P., Foley, B., Maree, A. O., Ryan, R. J., Tolan, M. J., Young, V., et al. (2019) · QJM · doi:10.1093/qjmed/hcz134 · Cited by 12
Treatment of Complicated Gram-Positive Bacteremia and Infective Endocarditis
Schellong, P., Joean, O., Pletz, M. W., Hagel, S., & Weis, S. (2024) · Drugs · doi:10.1007/s40265-024-02135-z · Cited by 13
A Review on Updated Species List of Viridans Streptococci causing Infective Endocarditis
Lakshmi, S. S. J., & Leela, K. V. (2022) · Journal of Pure and Applied Microbiology · doi:10.22207/jpam.16.3.26 · Cited by 10
Infective endocarditis: a tertiary referral centre experience from Turkey.
Ağca, F. V., Demircan, N., Peker, T., Arı, H., Karaağaç, K., Özlük, Ö. A., Yılmaz, M., & Tenekecioğlu, E. (2015) · Europe PMC (PubMed Central) · Cited by 15
Yavuz, S. Ş., Akar, A., Aydoğdu, S., Berzeg-Deniz, D., Demir, H., Hazırolan, T., Özatık, M. A., Özer, N., Sarğın, M., Topçuoğlu, N., et al. (2020) · Turkish Journal of Thoracic and Cardiovascular Surgery · doi:10.5606/tgkdc.dergisi.2020.01954 · Cited by 13
Moreillon, P. (2010) · Elsevier eBooks · doi:10.1016/b978-0-323-04579-7.00047-2 · Cited by 11
Leung, M. H. Y., Ling, C. L., Ciesielczuk, H., Lockwood, J., Thurston, S., Charalambous, B. M., & Gillespie, S. H. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.00131-12 · Cited by 10
“However, invasive diseases caused by other related viridans group streptococci had been documented (16, 26, 31).”
BackgroundHirai, Y., Ainoda, Y., Shoji, T., & Totsuka, K. (2010) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-010-0033-0 · Cited by 8
“Although sensitivities to penicillin G and ceftriaxone correlated with each other [10], cases of infectious endocarditis because of streptococci with decreased sensitivities or resistances to ceftriaxone and penicillin G have increasingly been reported over the past decade [27].”
BackgroundSarangi, J., Ido, A., Ito, M., Iinuma, C., Doyama, Y., Jin, W., Wachino, J., Suzuki, M., Iguchi, M., Yagi, T., et al. (2024) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01179-23 · Cited by 7
Wo, S., Dubrovskaya, Y., Siegfried, J., Papadopoulos, J., & Jen, S.-P. P. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa542 · Cited by 6
“Knoll and colleagues conducted a single-site observational study focusing on treatment efficacy in 29 adult patients with IE due to penicillin-resistant VGS [13].”
BackgroundApiwattanakul, N., Wanitkun, S., Chongtrakool, P., & Sirinavin, S. (2008) · PubMed · Cited by 6
New trends in infective endocarditis
Fariñas, M. C., Llinares, P., Almirante, B., Barberán, J., Colmenero, J., Garau, J., Gudiol, F., Hernández‐Quero, J., Mensa, J., Montejo, M., et al. (2011) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/s0213-005x(11)70033-7 · Cited by 7
Watanabe, Y., Nagao, Y., Endoh, H., Yamane, I., Hirata, M., & Hatakeyama, K. (2019) · Clinical Case Reports · doi:10.1002/ccr3.2528 · Cited by 5
Infective Endocarditis: New Challenges in a Classic Disease
Cuervo, G., Meneses, M. H., Falces, C., Quintana, E., Vidal, B., Marco, F., Perissinotti, A., Carratalà, J., Miró, J. M., & The Hospital Clinic and the Hospital of Bellvitge Endocarditis Team Investigators (2022) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0042-1742482 · Cited by 6
Karchmer, A. W. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0398-6.00067-6 · Cited by 7
Escrihuela-Vidal, F., Fernández‐Hidalgo, N., Muñóz, P., Villamarín, M., Jiménez-García, N., Escudero, E. M., Marcos, F. J. M., Cuervo, G., Boix-Palop, L., Berbel, D., et al. (2024) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkae345 · Cited by 3
Li, H., Yang, K., Liu, H., Cao, S., Bao, Y., Feng, L., Zhang, L., Niu, J., & Tian, T. (2025) · Microorganisms · doi:10.3390/microorganisms13122814 · Cited by 3
“For example, resistant oral streptococci (e.g., to β -lactams, clindamycin, erythromycin) are implicated in infective endocarditis [3,18].”
Farahani, P., Ruffin, F., Taherahmadi, M., Webster, M. E., Korn, R. E., Cantrell, S. E., Wahid, L., Fowler, V. G., & Thaden, J. T. (2024) · Microorganisms · doi:10.3390/microorganisms12112226 · Cited by 3
Infective endocarditis: a consumptive disease among the elderly
Takayasu, V., Lima, F. R., & de Campos, F. P. F. (2011) · Autopsy and Case Reports · doi:10.4322/acr.2011.014 · Cited by 4
Bacteriemia e infecciones endovasculares por grampositivos: nuevas opciones terapéuticas
Almirante, B. (2008) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1157/13123565 · Cited by 3
Hoen, B., Tornos, P., Antunes, M. J., Lekakis, J. P., Lengyel, M., Naber, C. K., & Zamorano, J. L. (2009) · Cited by 3
Guerrero, J. S. (2008) · Journal of the California Dental Association · doi:10.1080/19424396.2008.12224250 · Cited by 2
Habib, G., Hoen, B., Tornos, P., Thuny, F., Prendergast, B., Vilacosta, I., Moreillon, P., Antunes, M. J., Thilén, U. J., Lekakis, J. P., et al. (2009) · Revista Española de Cardiología (English Edition) · doi:10.1016/s1885-5857(09)73540-6 · Cited by 3
Thuny, F., Habib, G., Raoult, D., & Fournier, P. (2016) · Elsevier eBooks · doi:10.1016/b978-0-7020-6285-8.00051-4 · Cited by 1
Kaplan, S. L., & Vallejo, J. G. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-82763-8.00026-1 · Cited by 1
Avaliação da microbiota bucal em pacientes sob uso crônico de penicilina G benzatina
de Aguiar, A. A. (2009) · doi:10.11606/t.5.2009.tde-24092009-171538 · Cited by 1
Beleslin, B., Deljanin, M., Kanjuh, V., Parapid, B. J., Giga, V. L., Prostran, M. S., Angelkov, L., Balinovac, J., Bikicki, M., Ambrosio, G., et al. (2013)
대한감염학회, 대한화학요법학회, 대한임상미생물학회, 대한심장학회, 대한흉부외과학회, & Kim, T. H. (2011) · Infection and Chemotherapy
Starke, J. R. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-4044-6.50037-6
Understanding the resistome of the human microbiome: A metagenomic approach
Barik, S., Kannoth, S., Deepthi, M., José, M., Prabhu, D. C., Sadanandan, S., & Grace, T. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-91631-8.00016-0 · Cited by 1
Combined Antimicrobial Therapy for Infective Endocarditis
Gomez-Villegas, S. I., Miller, W. R., & Arias, C. A. (2024) · Springer eBooks · doi:10.1007/978-3-031-65839-6_16
Enterococcal and Viridans Streptococcal Infections
McNeil, J. C. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-82763-8.00084-4
Kuri, K., Kinoshita-Daitoku, R., Arakawa, Y., Shibayama, K., & Kimura, K. (2025) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2025.102846
Tazi, A., Moing, V. L., Goehringer, F., Lecomte, R., Béraud, G., Chirouze, C., Ferry, T., Bot, A. L., Moby, V., Tribouilloy, C. M., et al. (2026) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-026-05463-y
Metadata
- Authors
- Knoll, B., Tleyjeh, I. M., Steckelberg, J. M., Wilson, W. R., & Baddour, L. M.
- Affiliations
- Mayo Clinic (US)
- King Fahd Medical City (SA)
- Corresponding author
- Knoll, B.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-06-15
- Volume
- 44
- Issue
- 12
- Pages
- 1585-1592
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2155164226
- Semantic Scholar
- d87aa556a8baf60eef6127697f581d185034d192
- Cited by
- 70
- References
- 29
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 6 · 2023: 2 · 2022: 3 · 2021: 2 · 2020: 4 · 2019: 5 · 2018: 1 · 2017: 1 · 2016: 2 · 2015: 5 · 2014: 1 · 2013: 4 · 2012: 5
- FWCI
- 3.90
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Mayo Clinic
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Health Sciences › Medicine › Infectious Diseases › Streptococcal Infections and Treatments
- Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
- Keywords
- infective endocarditis, Streptococcus viridans, penicillin resistance, antibiotic regimens, ceftriaxone, vancomycin, aminoglycosides, native valve endocarditis, prosthetic valve endocarditis, treatment outcomes
- MeSH terms
- Adult, Aged, Cross Infection, Endocarditis, Bacterial, Female, Heart Valve Prosthesis, Hospitals, Teaching, Humans, Male, Microbial Sensitivity Tests, Middle Aged, Penicillin Resistance, Retrospective Studies, Streptococcal Infections, Cohort Studies, Treatment Outcome, Practice Guidelines as Topic, Community-Acquired Infections, Disease-Free Survival, Viridans Streptococci
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.